Clinical Trial Update: Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S [Phase 1, Phase 2]

View source ↗

Summary

This report summarizes safety and early efficacy data from Phase 1/2 trials of two malaria vaccine candidates, FMP1 and RTS,S, in Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• FMP1 (Falciparum merozoite surface protein 1 vaccine (FMP1))
• RTS,S (RTS,S malaria vaccine (RTS,S/AS01))

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Falciparum | Phase 1, Phase 2 | Status: COMPLETED